Table 2.
Self-reported antiretroviral adherence and clinical parameters at 30- and 90-day follow-up among participants with <95% adherence at baseline (N=57).
| Parameter | Users (n=19)a | Nonusers (n=38)b | P valuec | ||
| Self-reported antiretroviral therapy adherence, n (%) | |||||
|
|
30-day follow-up | .12 | |||
|
|
|
≥95% | 13 (81) | 17 (58) |
|
|
|
90-day follow-up | .73 | |||
|
|
|
≥95% | 7 (46) | 9 (40) |
|
| HIV viral load , n (%) | |||||
|
|
Baseline | .30 | |||
|
|
|
<40 copies/mL | 12 (63) | 17 (48) |
|
|
|
Follow-up | .74 | |||
|
|
|
<40 copies/mL | 12 (75) | 20 (69) |
|
| CD4+ T-cell count , n (%) | |||||
|
|
Baseline | .13 | |||
|
|
|
0-200 cells/mL3 | 5 (26) | 2 (5) |
|
|
|
|
201-500 cells/mL3 | 6 (31) | 14 (40) |
|
|
|
|
>500 cells/mL3 | 8 (42) | 19 (54) |
|
|
|
Follow-up | .36 | |||
|
|
|
0-200 cells/mL3 | 4 (26) | 3 (10) |
|
|
|
|
201-500 cells/mL3 | 5 (33) | 10 (34) |
|
|
|
|
>500 cells/mL3 | 6 (40) | 16 (55) |
|
aSome variables might not be total 19 owing to missing data.
bSome variables might not be total 38 owing to missing data.
cP value derived using chi-square analysis comparing proportions in each category.